News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioCryst Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Bio NC
Top 5 Biotech Winners and Losers of Q1 2016
March 31, 2016
·
3 min read
FDA
FDA Approves Biocryst Pharmaceuticals’s Intravenous Flu Drug Rapivab
December 22, 2014
·
2 min read
BioCapital
Ebola Clinical Trials: Big Name Players In The Ebola Race
October 20, 2014
·
12 min read
Biotech Beach
The Day In Review: Novartis Pharmaceuticals Corporation Gets Approval For Hypertensive Drug Tekturna
March 6, 2007
·
1 min read
Biotech Beach
The Week In Review: Biotech Ends Q3 With A Bang
October 3, 2006
·
1 min read
Biotech Beach
The Day In Review: Amgen Buys Avidia, Inc. For $290 Million
October 3, 2006
·
1 min read
Biotech Bay
The Day In Review: Amgen Gets Approval For Vectibix
September 27, 2006
·
1 min read
Biotech Beach
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
August 7, 2006
·
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Buys Obesity Compound From Bayer Corporation
June 14, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
January 26, 2026
·
7 min read
Press Releases
Astria Stockholders Vote to Approve Acquisition by BioCryst
January 22, 2026
·
2 min read
Press Releases
BioCryst Announces Preliminary Full Year 2025 ORLADEYO® (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range
January 12, 2026
·
11 min read
Press Releases
BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 6, 2026
January 6, 2026
·
1 min read
Press Releases
BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years
December 12, 2025
·
9 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2025
December 4, 2025
·
1 min read
Press Releases
BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition
December 3, 2025
·
7 min read
Press Releases
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 13, 2025
·
15 min read
Press Releases
BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated with One Year of ORLADEYO® (berotralstat)
November 7, 2025
·
12 min read
